Concepedia

Publication | Open Access

Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study

DOIFull Paper Access

25

Citations

30

References

2021

Year

Garyphallia Poulakou, Evangelos Dimakakos, Konstantinos G. Kyriakoulis, Vasiliki Rapti, Ioannis P. Trontzas, CHARALAMPOS THANOS, Mahmoud Abdel‐Rasoul, THEODORA VANTANA, Konstantinos Leontis, Eleni Kakalou,
In Vivo

Abstract

Anticoagulation treatment (particularly intermediate dosage) appears to have positive impact on COVID-19 inpatients' prognosis by inhibiting both coagulation and inflammatory cascades.

References

YearCitations

Page 1